The NBDF-Sanofi Career Development Award supports established investigators studying bleeding disorders, funding innovative research on disease, treatments, and new technologies to advance understanding and care.
Funder: National Bleeding Disorders Foundation
Due Dates (Anticipated): February 2027 (Letter of Intent) | April 2027 (Full application)
Funding Amounts: Up to $70,000 annually for a maximum of three years
Summary: Supports innovative research to advance understanding and treatment of bleeding disorders.
Key Information: Recipients must devote at least 75% of their working time to the funded project.
The National Bleeding Disorders Foundation (NBDF), with sponsorship from Sanofi, offers this award to established investigators committed to bleeding disorders research. It especially encourages innovative studies that develop novel technologies or therapies. Projects may investigate disease and treatment at the subcellular, cellular, animal, or human and patient levels.
Areas of interest include gene transfer and other new treatments; the genetic and immunologic basis of inhibitor development; and clotting factor structure and function. NBDF also highlights longer-lived factors, biologically active oral molecules, improved protein delivery, and assays that can assess treatments and gene therapy studies.